RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 23, 2020

Primary Completion Date

March 21, 2022

Study Completion Date

May 4, 2022

Conditions
COVID-19
Interventions
DRUG

FoTv

8 capsules three times a day for 14 consecutive days.

Trial Locations (2)

90095

University of California, Los Angeles, Los Angeles

92093

University of California, San Diego, San Diego

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

collaborator

University of California, Irvine

OTHER

lead

Gordon Saxe

OTHER

NCT04667247 - RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19 | Biotech Hunter | Biotech Hunter